Valuation : Alpha IVF Group

Market Cap 1.19B 291M 250M 236M 215M 402M 27.71B 404M 2.79B 1.08B 14.16B 1.09B 1.07B 44.71B P/E 2026
22.7x
P/E 2027 * 18.1x
Enterprise Value 1.19B 291M 250M 236M 215M 402M 27.71B 404M 2.79B 1.08B 14.16B 1.09B 1.07B 44.71B EV / Sales 2026
6.09x
EV / Sales 2027 * 4.85x
Free-Float
23.4%
Yield 2026
4%
Yield 2027 * 4.49%
1 day-2.00%
1 week-5.77%
Current month-7.55%
1 month-10.91%
6 months-5.77%
Current year-16.95%
1 week 0.24
Extreme 0.245
0.26
1 month 0.24
Extreme 0.245
0.28
Current year 0.24
Extreme 0.235
0.31
1 year 0.24
Extreme 0.235
0.34
3 years 0.24
Extreme 0.235
0.38
5 years 0.24
Extreme 0.235
0.38
10 years 0.24
Extreme 0.235
0.38
Date Insider Type Main position Quantity % Market Cap. Importance
4/30/26 Free

Chief Executive Officer

500,000 0.0103%
3/18/26 Others

Chief Executive Officer

1,555,200,000 32.0000%
3/18/26 Others

Chief Executive Officer

1,555,200,000 32.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-2.00%-5.77%-19.67% - 298M
+0.44%+0.86%+24.21%+16.87% 223B
-0.19%-1.01%+3.13%-17.52% 144B
+0.88%-4.34%-24.84%+18.45% 124B
-0.04%-6.49%-58.42%-16.54% 65.19B
-0.62%-5.03%+7.44%+16.35% 49.99B
-0.79%-1.55%-18.62%-13.39% 50.49B
-1.43%-3.45%+12.97%+26.98% 41.4B
+0.47%-0.25%+30.85%+53.59% 39.59B
-2.87%-1.03%+108.80%+29.45% 31.87B
Average -0.72%-2.12%+6.58%+12.69% 76.98B
Weighted average by Cap. -0.20%-1.80%+4.70%+8.78%

Financials

2026 2027 *
Net sales 202M 49.71M 42.73M 40.27M 36.69M 68.51M 4.73B 68.87M 477M 184M 2.42B 187M 183M 7.63B 244M 60.02M 51.6M 48.62M 44.3M 82.72M 5.71B 83.16M 576M 222M 2.92B 225M 220M 9.21B
Net income 53.6M 13.18M 11.33M 10.67M 9.73M 18.16M 1.25B 18.26M 126M 48.83M 640M 49.46M 48.39M 2.02B 65.5M 16.1M 13.84M 13.04M 11.88M 22.19M 1.53B 22.31M 154M 59.67M 782M 60.44M 59.13M 2.47B
Net Debt - -
Logo Alpha IVF Group
Alpha IVF Group Bhd is a Malaysia-based fertility science, research, and advancement company. The company engages in the provision of assisted reproductive services through its specialist fertility care centers. The company offers access to comprehensive fertility services, technology, and labs across its fertility centers. Its assisted reproductive technologies (ART) refer to a range of medical technologies and treatments complemented with laboratory technologies and procedures to assist individuals or couples in overcoming the challenges of infertility. The company’s assisted reproductive services (ARS) include support services, such as fertility assessment, diagnostics and testing, monitoring, preconception care, and counseling. The medical technologies and treatments of ART are primarily carried out by medical specialists in obstetrics and gynecology, who are also responsible for the prescription of fertility and other related drugs.
Employees
-
Date Price Change Volume
26-09-09 MYR 0.2450 -2.00% 1,037,200
26-09-08 MYR 0.2500 0.00% 655,600
26-09-07 MYR 0.2500 -1.96% 5,641,400
26-09-04 MYR 0.2550 0.00% 2,330,200
26-09-03 MYR 0.2550 -1.92% 3,299,300
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.2450MYR
Average target price
0.3300MYR
Spread / Average Target
+34.69%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 0303 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!